| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | STARD13 ARHGEF28 SIPA1L3 PSD3 ARHGEF18 GMIP ARHGEF11 RASA4 FARP1 RASA4B RIMS1 PLCG1 ARHGEF3 PLXNB1 | 1.19e-06 | 507 | 114 | 14 | GO:0060589 |
| GeneOntologyMolecularFunction | GTPase regulator activity | STARD13 ARHGEF28 SIPA1L3 PSD3 ARHGEF18 GMIP ARHGEF11 RASA4 FARP1 RASA4B RIMS1 PLCG1 ARHGEF3 PLXNB1 | 1.19e-06 | 507 | 114 | 14 | GO:0030695 |
| GeneOntologyMolecularFunction | glucokinase activity | 3.19e-04 | 5 | 114 | 2 | GO:0004340 | |
| GeneOntologyMolecularFunction | hexokinase activity | 3.19e-04 | 5 | 114 | 2 | GO:0004396 | |
| GeneOntologyMolecularFunction | fructokinase activity | 3.19e-04 | 5 | 114 | 2 | GO:0008865 | |
| GeneOntologyMolecularFunction | guanyl-nucleotide exchange factor activity | 3.65e-04 | 231 | 114 | 7 | GO:0005085 | |
| GeneOntologyBiologicalProcess | regulation of small GTPase mediated signal transduction | STARD13 SPRY2 ARHGEF28 SIPA1L3 PSD3 ARHGEF18 GMIP ARHGEF11 SH2B2 RASA4 RASA4B ARHGEF3 PLXNB1 | 4.47e-08 | 333 | 115 | 13 | GO:0051056 |
| GeneOntologyBiologicalProcess | small GTPase-mediated signal transduction | STARD13 SPRY2 ARHGEF28 SIPA1L3 PSD3 ARHGEF18 GMIP ARHGEF11 SH2B2 RASA4 FARP1 RASA4B ARHGEF3 PLXNB1 | 1.82e-06 | 538 | 115 | 14 | GO:0007264 |
| GeneOntologyCellularComponent | Cul4-RING E3 ubiquitin ligase complex | 5.55e-05 | 38 | 115 | 4 | GO:0080008 | |
| GeneOntologyCellularComponent | basement membrane | 5.85e-05 | 122 | 115 | 6 | GO:0005604 | |
| GeneOntologyCellularComponent | Golgi lumen | 3.42e-04 | 109 | 115 | 5 | GO:0005796 | |
| GeneOntologyCellularComponent | actomyosin | 4.74e-04 | 117 | 115 | 5 | GO:0042641 | |
| MousePheno | abnormal optic nerve morphology | 1.87e-05 | 182 | 88 | 8 | MP:0001330 | |
| Domain | - | ARHGEF28 PSD3 ARHGEF18 ARHGEF11 SH2B2 SHC3 RASA4 FARP1 RASA4B PLCG1 ARHGEF3 EPB41L1 | 3.66e-06 | 391 | 111 | 12 | 2.30.29.30 |
| Domain | PH | ARHGEF28 PSD3 ARHGEF18 ARHGEF11 SH2B2 RASA4 FARP1 RASA4B PLCG1 ARHGEF3 | 6.24e-06 | 278 | 111 | 10 | SM00233 |
| Domain | PH_DOMAIN | ARHGEF28 PSD3 ARHGEF18 ARHGEF11 SH2B2 RASA4 FARP1 RASA4B PLCG1 ARHGEF3 | 6.44e-06 | 279 | 111 | 10 | PS50003 |
| Domain | PH_domain | ARHGEF28 PSD3 ARHGEF18 ARHGEF11 SH2B2 RASA4 FARP1 RASA4B PLCG1 ARHGEF3 | 6.65e-06 | 280 | 111 | 10 | IPR001849 |
| Domain | PH_dom-like | ARHGEF28 PSD3 ARHGEF18 ARHGEF11 SH2B2 SHC3 RASA4 FARP1 RASA4B PLCG1 ARHGEF3 EPB41L1 | 8.73e-06 | 426 | 111 | 12 | IPR011993 |
| Domain | LRRFIP1/2 | 3.50e-05 | 2 | 111 | 2 | IPR019139 | |
| Domain | LRRFIP | 3.50e-05 | 2 | 111 | 2 | PF09738 | |
| Domain | DH_1 | 3.62e-05 | 63 | 111 | 5 | PS00741 | |
| Domain | RhoGEF | 5.24e-05 | 68 | 111 | 5 | SM00325 | |
| Domain | RhoGEF | 6.03e-05 | 70 | 111 | 5 | PF00621 | |
| Domain | DH_2 | 6.03e-05 | 70 | 111 | 5 | PS50010 | |
| Domain | - | 6.45e-05 | 71 | 111 | 5 | 1.20.900.10 | |
| Domain | DH-domain | 6.45e-05 | 71 | 111 | 5 | IPR000219 | |
| Domain | PH | 6.75e-05 | 229 | 111 | 8 | PF00169 | |
| Domain | - | 1.05e-04 | 3 | 111 | 2 | 4.10.1130.10 | |
| Domain | RasGAP_dom | 1.56e-04 | 18 | 111 | 3 | IPR001936 | |
| Domain | Rho_GTPase_activation_prot | 1.79e-04 | 88 | 111 | 5 | IPR008936 | |
| Domain | SEA | 2.90e-04 | 22 | 111 | 3 | PF01390 | |
| Domain | SEA | 3.32e-04 | 23 | 111 | 3 | PS50024 | |
| Domain | SEA_dom | 3.32e-04 | 23 | 111 | 3 | IPR000082 | |
| Domain | Hexokinase_2 | 3.46e-04 | 5 | 111 | 2 | PF03727 | |
| Domain | Hexokinase_BS | 3.46e-04 | 5 | 111 | 2 | IPR019807 | |
| Domain | Hexokinase_C | 3.46e-04 | 5 | 111 | 2 | IPR022673 | |
| Domain | Hexokinase_N | 3.46e-04 | 5 | 111 | 2 | IPR022672 | |
| Domain | Hexokinase_1 | 3.46e-04 | 5 | 111 | 2 | PF00349 | |
| Domain | HEXOKINASE_2 | 3.46e-04 | 5 | 111 | 2 | PS51748 | |
| Domain | HEXOKINASE_1 | 3.46e-04 | 5 | 111 | 2 | PS00378 | |
| Domain | C2_dom | 4.43e-04 | 164 | 111 | 6 | IPR000008 | |
| Domain | Hexokinase | 5.17e-04 | 6 | 111 | 2 | IPR001312 | |
| Domain | BTK | 1.23e-03 | 9 | 111 | 2 | SM00107 | |
| Domain | Cl-channel_core | 1.23e-03 | 9 | 111 | 2 | IPR014743 | |
| Domain | - | 1.23e-03 | 9 | 111 | 2 | 1.10.3080.10 | |
| Domain | Voltage_CLC | 1.23e-03 | 9 | 111 | 2 | PF00654 | |
| Domain | Cl-channel_volt-gated | 1.23e-03 | 9 | 111 | 2 | IPR001807 | |
| Domain | Znf_Btk_motif | 1.23e-03 | 9 | 111 | 2 | IPR001562 | |
| Domain | BTK | 1.23e-03 | 9 | 111 | 2 | PF00779 | |
| Domain | ZF_BTK | 1.23e-03 | 9 | 111 | 2 | PS51113 | |
| Domain | C2 | 1.36e-03 | 137 | 111 | 5 | SM00239 | |
| Domain | PAS_9 | 1.53e-03 | 10 | 111 | 2 | PF13426 | |
| Domain | PDZ | 1.54e-03 | 141 | 111 | 5 | PF00595 | |
| Domain | C2 | 1.59e-03 | 142 | 111 | 5 | PS50004 | |
| Domain | GDS_CDC24_CS | 1.60e-03 | 39 | 111 | 3 | IPR001331 | |
| Domain | - | 1.91e-03 | 148 | 111 | 5 | 2.60.40.150 | |
| Domain | PDZ | 1.91e-03 | 148 | 111 | 5 | SM00228 | |
| Domain | - | 2.02e-03 | 150 | 111 | 5 | 2.30.42.10 | |
| Domain | PDZ | 2.08e-03 | 151 | 111 | 5 | PS50106 | |
| Domain | PDZ | 2.14e-03 | 152 | 111 | 5 | IPR001478 | |
| Domain | FA | 2.62e-03 | 13 | 111 | 2 | PF08736 | |
| Domain | FERM-adjacent | 2.62e-03 | 13 | 111 | 2 | IPR014847 | |
| Domain | FA | 2.62e-03 | 13 | 111 | 2 | SM01195 | |
| Domain | RasGAP | 3.04e-03 | 14 | 111 | 2 | SM00323 | |
| Domain | SEA | 3.04e-03 | 14 | 111 | 2 | SM00200 | |
| Domain | K_chnl_volt-dep_EAG/ELK/ERG | 3.04e-03 | 14 | 111 | 2 | IPR003938 | |
| Domain | RasGAP_CS | 3.04e-03 | 14 | 111 | 2 | IPR023152 | |
| Domain | RasGAP | 3.49e-03 | 15 | 111 | 2 | PF00616 | |
| Domain | RAS_GTPASE_ACTIV_1 | 3.49e-03 | 15 | 111 | 2 | PS00509 | |
| Domain | RAS_GTPASE_ACTIV_2 | 3.49e-03 | 15 | 111 | 2 | PS50018 | |
| Domain | - | 3.75e-03 | 333 | 111 | 7 | 2.130.10.10 | |
| Domain | WD40/YVTN_repeat-like_dom | 3.88e-03 | 335 | 111 | 7 | IPR015943 | |
| Domain | CBS | 3.98e-03 | 16 | 111 | 2 | SM00116 | |
| Domain | - | 3.98e-03 | 16 | 111 | 2 | 1.10.506.10 | |
| Domain | Cadherin_CS | 4.07e-03 | 109 | 111 | 4 | IPR020894 | |
| Domain | WD40 | 4.52e-03 | 259 | 111 | 6 | PF00400 | |
| Domain | CADHERIN_1 | 4.63e-03 | 113 | 111 | 4 | PS00232 | |
| Domain | Cadherin | 4.63e-03 | 113 | 111 | 4 | PF00028 | |
| Domain | CADHERIN_2 | 4.78e-03 | 114 | 111 | 4 | PS50268 | |
| Domain | - | 4.78e-03 | 114 | 111 | 4 | 2.60.40.60 | |
| Domain | CA | 4.93e-03 | 115 | 111 | 4 | SM00112 | |
| Domain | Cadherin-like | 5.08e-03 | 116 | 111 | 4 | IPR015919 | |
| Domain | WD40 | 5.33e-03 | 268 | 111 | 6 | SM00320 | |
| Domain | Cadherin | 5.40e-03 | 118 | 111 | 4 | IPR002126 | |
| Domain | VWC_out | 5.60e-03 | 19 | 111 | 2 | SM00215 | |
| Domain | WD40_repeat | 5.72e-03 | 272 | 111 | 6 | IPR001680 | |
| Pathway | REACTOME_RHOA_GTPASE_CYCLE | 1.82e-06 | 142 | 83 | 8 | MM15576 | |
| Pathway | REACTOME_RHOA_GTPASE_CYCLE | 2.61e-06 | 149 | 83 | 8 | M41805 | |
| Pathway | PID_RHOA_REG_PATHWAY | 7.10e-06 | 46 | 83 | 5 | M68 | |
| Pathway | REACTOME_RHO_GTPASE_CYCLE | STARD13 ARHGEF28 ARHGEF18 GMIP ARHGEF11 SENP1 DST FARP1 PKN1 ARHGEF3 PLXNB1 | 5.05e-05 | 439 | 83 | 11 | MM15595 |
| Pathway | REACTOME_RHOB_GTPASE_CYCLE | 5.24e-05 | 69 | 83 | 5 | MM15596 | |
| Pathway | REACTOME_RHOB_GTPASE_CYCLE | 5.62e-05 | 70 | 83 | 5 | M41806 | |
| Pathway | REACTOME_RHO_GTPASE_CYCLE | STARD13 ARHGEF28 ARHGEF18 GMIP ARHGEF11 SENP1 DST FARP1 PKN1 ARHGEF3 PLXNB1 | 6.31e-05 | 450 | 83 | 11 | M27078 |
| Pubmed | SIN3B SYNE1 SIPA1L3 HECTD4 ARHGEF18 BCOR ARHGEF11 DNAJC6 SENP1 DST AP2A2 FARP1 SMARCC2 PKN1 RIMS1 PARD3 EPB41L1 LRRFIP1 LRRFIP2 | 7.71e-10 | 963 | 119 | 19 | 28671696 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | HSPG2 SPRY2 FRAS1 SZT2 SIPA1L3 HECTD4 AMBRA1 WRAP53 ARHGEF11 STK11IP SH2B2 RNF43 MXD4 FAT1 EHBP1L1 DST PKN1 PLCG1 HECTD1 WDR24 | 1.16e-09 | 1105 | 119 | 20 | 35748872 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | PPAN ZC3H13 ZMYND8 FNBP4 MYO18A RREB1 WRAP53 BCOR YTHDC1 NSUN2 TAF3 SMARCC2 PKN1 RIMS1 PARD3 LRRFIP1 | 9.94e-09 | 774 | 119 | 16 | 15302935 |
| Pubmed | HK1 TNC SYNE1 PPFIA2 SIPA1L3 MYO18A PSD3 ARHGEF11 DNAJC6 DST CLCN6 AP2A2 FARP1 SMARCC2 RIMS1 MTDH EPB41L1 LRRFIP1 LRRFIP2 | 4.09e-07 | 1431 | 119 | 19 | 37142655 | |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | ZBTB38 HK1 SYNE1 ZC3H13 ZMYND8 HECTD4 FNBP4 MYO18A YTHDC1 TAF3 EHBP1L1 DST FARP1 SMARCC2 MTDH PLXNB1 | 9.24e-07 | 1082 | 119 | 16 | 38697112 |
| Pubmed | PRRG1 HBS1L HK3 ZC3H13 ZNF212 TTC14 ARHGEF18 TACC2 BCOR FARP1 PLCG1 ARHGEF3 PARD3 TAPBP MTDH PLXNB1 | 9.46e-07 | 1084 | 119 | 16 | 11544199 | |
| Pubmed | SIN3B HBS1L ARHGEF28 SIPA1L3 TTC14 ARHGEF18 VARS2 ENPP4 YTHDC1 AP2A2 HECTD1 | 1.11e-06 | 493 | 119 | 11 | 15368895 | |
| Pubmed | Dynamic expression patterns of ECM molecules in the developing mouse olfactory pathway. | 3.23e-06 | 9 | 119 | 3 | 18570250 | |
| Pubmed | SIN3B HBS1L PPAN NEBL NOP53 SYNE1 SIPA1L3 ZMYND8 WRAP53 BCOR ARHGEF11 YTHDC1 DST FARP1 PARD3 EPN1 TAPBP EPB41L1 | 3.45e-06 | 1497 | 119 | 18 | 31527615 | |
| Pubmed | Acetylcholinesterase activity in the brain of dystonia musculorum (Dst(dt-J)) mutant mice. | 1.16e-05 | 2 | 119 | 2 | 21978551 | |
| Pubmed | CAPRI regulates Ca(2+)-dependent inactivation of the Ras-MAPK pathway. | 1.16e-05 | 2 | 119 | 2 | 11448776 | |
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 18647752 | ||
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 16832351 | ||
| Pubmed | Sirtuin 6 (SIRT6) regulates redox homeostasis and signaling events in human articular chondrocytes. | 1.16e-05 | 2 | 119 | 2 | 33600943 | |
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 7524681 | ||
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 16041389 | ||
| Pubmed | 1.31e-05 | 225 | 119 | 7 | 12168954 | ||
| Pubmed | HBS1L FRAS1 PPAN HK1 NOP53 SIRT6 WRAP53 ZNF469 AP2A2 PLCG1 MTDH | 1.59e-05 | 653 | 119 | 11 | 33742100 | |
| Pubmed | 1.88e-05 | 159 | 119 | 6 | 30581152 | ||
| Pubmed | A bead-based approach for large-scale identification of in vitro kinase substrates. | 2.17e-05 | 163 | 119 | 6 | 22113938 | |
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | 2.17e-05 | 440 | 119 | 9 | 34244565 | |
| Pubmed | Mucin gene expression in human laryngeal epithelia: effect of laryngopharyngeal reflux. | 3.07e-05 | 18 | 119 | 3 | 18834073 | |
| Pubmed | 3.07e-05 | 18 | 119 | 3 | 12799088 | ||
| Pubmed | STARD13 CUX2 PPAN HK1 PCDHGA10 SYNE1 PPFIA2 SIPA1L3 MYO18A KRBA2 DST STS AP2A2 SMARCC2 RIMS1 MTDH | 3.38e-05 | 1442 | 119 | 16 | 35575683 | |
| Pubmed | 3.47e-05 | 3 | 119 | 2 | 26855992 | ||
| Pubmed | 3.47e-05 | 3 | 119 | 2 | 19669783 | ||
| Pubmed | Interaction of plexin-B1 with PDZ domain-containing Rho guanine nucleotide exchange factors. | 3.47e-05 | 3 | 119 | 2 | 12220504 | |
| Pubmed | CD28 inhibits T cell adhesion by recruiting CAPRI to the plasma membrane. | 3.47e-05 | 3 | 119 | 2 | 25637021 | |
| Pubmed | Multiple interactions of auxilin 1 with clathrin and the AP-2 adaptor complex. | 3.47e-05 | 3 | 119 | 2 | 11470803 | |
| Pubmed | Phospholipase Cgamma activates Ras on the Golgi apparatus by means of RasGRP1. | 3.47e-05 | 3 | 119 | 2 | 12845332 | |
| Pubmed | SIRT6 promotes transcription of a subset of NRF2 targets by mono-ADP-ribosylating BAF170. | 3.47e-05 | 3 | 119 | 2 | 31216030 | |
| Pubmed | 3.47e-05 | 3 | 119 | 2 | 26770020 | ||
| Pubmed | Ontogeny of CLCN3 chloride channel gene expression in human pulmonary epithelium. | 3.47e-05 | 3 | 119 | 2 | 11306429 | |
| Pubmed | 4.27e-05 | 20 | 119 | 3 | 21689717 | ||
| Pubmed | An improved smaller biotin ligase for BioID proximity labeling. | 6.75e-05 | 123 | 119 | 5 | 26912792 | |
| Pubmed | Direct neuronal glucose uptake heralds activity-dependent increases in cerebral metabolism. | 6.93e-05 | 4 | 119 | 2 | 25904018 | |
| Pubmed | 6.93e-05 | 4 | 119 | 2 | 26428891 | ||
| Pubmed | 6.93e-05 | 4 | 119 | 2 | 19265123 | ||
| Pubmed | 6.93e-05 | 4 | 119 | 2 | 21460216 | ||
| Pubmed | High 18F-FDG uptake in PMAH correlated with normal expression of Glut1, HK1, HK2, and HK3. | 6.93e-05 | 4 | 119 | 2 | 25766729 | |
| Pubmed | 6.93e-05 | 4 | 119 | 2 | 10366446 | ||
| Pubmed | Formation and contraction of multicellular actomyosin cables facilitate lens placode invagination. | 6.93e-05 | 4 | 119 | 2 | 32113830 | |
| Pubmed | 6.93e-05 | 4 | 119 | 2 | 16234249 | ||
| Pubmed | Stromal Fat4 acts non-autonomously with Dchs1/2 to restrict the nephron progenitor pool. | 7.50e-05 | 24 | 119 | 3 | 26116661 | |
| Pubmed | HBS1L FRAS1 ARHGEF28 AMBRA1 GMIP NSUN2 DST EPN1 EPB41L1 PLXNB1 | 8.32e-05 | 650 | 119 | 10 | 38777146 | |
| Pubmed | 8.96e-05 | 529 | 119 | 9 | 14621295 | ||
| Pubmed | 9.85e-05 | 214 | 119 | 6 | 22199357 | ||
| Pubmed | Characterization of an exchangeable gene trap using pU-17 carrying a stop codon-beta geo cassette. | SIPA1L3 FNBP4 TACC2 PSMD12 YTHDC1 DNAJC6 PARD3 HECTD1 EPB41L1 | 9.90e-05 | 536 | 119 | 9 | 15840001 |
| Pubmed | SIPA1L3 FNBP4 TACC2 PSMD12 YTHDC1 DNAJC6 PARD3 HECTD1 EPB41L1 | 1.02e-04 | 538 | 119 | 9 | 10512203 | |
| Pubmed | STING-Mediated IFI16 Degradation Negatively Controls Type I Interferon Production. | 1.12e-04 | 316 | 119 | 7 | 31665637 | |
| Pubmed | 1.15e-04 | 5 | 119 | 2 | 20719962 | ||
| Pubmed | 1.15e-04 | 5 | 119 | 2 | 9915576 | ||
| Pubmed | Epsin is an EH-domain-binding protein implicated in clathrin-mediated endocytosis. | 1.15e-04 | 5 | 119 | 2 | 9723620 | |
| Pubmed | 1.15e-04 | 5 | 119 | 2 | 12183458 | ||
| Pubmed | 1.15e-04 | 5 | 119 | 2 | 15123640 | ||
| Pubmed | 1.15e-04 | 5 | 119 | 2 | 23935956 | ||
| Pubmed | ZNF212 BACH2 ZMYND8 AMBRA1 RREB1 BCOR RNF43 ZNF469 FAT1 SENP1 TAF3 SMARCC2 PARD3 | 1.20e-04 | 1116 | 119 | 13 | 31753913 | |
| Pubmed | SPRY2 DCHS2 ZBTB38 SYNE1 SIPA1L3 ZMYND8 HECTD4 CRTAC1 WRAP53 NSUN2 DST PLCG1 HECTD1 LRRFIP1 | 1.31e-04 | 1285 | 119 | 14 | 35914814 | |
| Pubmed | KCNH7 PPFIA2 MYO18A PSD3 TACC2 PSMD12 AP2A2 FARP1 SMARCC2 RIMS1 MTDH EPB41L1 LRRFIP1 | 1.47e-04 | 1139 | 119 | 13 | 36417873 | |
| Pubmed | 1.56e-04 | 147 | 119 | 5 | 16959763 | ||
| Pubmed | Sprouty2 regulates PI(4,5)P2/Ca2+ signaling and HIV-1 Gag release. | 1.73e-04 | 6 | 119 | 2 | 21762810 | |
| Pubmed | 1.73e-04 | 6 | 119 | 2 | 19110483 | ||
| Pubmed | Expression of CLCN voltage-gated chloride channel genes in human blood vessels. | 1.73e-04 | 6 | 119 | 2 | 10198195 | |
| Pubmed | 1.73e-04 | 6 | 119 | 2 | 12732633 | ||
| Pubmed | 1.73e-04 | 6 | 119 | 2 | 9486530 | ||
| Pubmed | FRAS1 HK1 SYNE1 ZC3H13 FNBP4 MYO18A PSD3 VARS2 DNAJC6 SENP1 FARP1 HTATSF1 PARD3 MTDH EPB41L1 | 1.73e-04 | 1487 | 119 | 15 | 33957083 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | KCNH8 PPFIA2 SIPA1L3 HECTD4 TTC14 FNBP4 ARHGEF18 SENP1 FARP1 PKN1 RIMS1 PLCG1 PARD3 HECTD1 EPB41L1 | 1.76e-04 | 1489 | 119 | 15 | 28611215 |
| Pubmed | 2.00e-04 | 347 | 119 | 7 | 17114649 | ||
| Pubmed | 2.10e-04 | 246 | 119 | 6 | 15345747 | ||
| Pubmed | 2.36e-04 | 35 | 119 | 3 | 15031101 | ||
| Pubmed | 2.36e-04 | 35 | 119 | 3 | 22991445 | ||
| Pubmed | 2.41e-04 | 7 | 119 | 2 | 25042397 | ||
| Pubmed | The bimodal regulation of epidermal growth factor signaling by human Sprouty proteins. | 2.41e-04 | 7 | 119 | 2 | 11983899 | |
| Pubmed | 2.41e-04 | 7 | 119 | 2 | 16059920 | ||
| Pubmed | 2.41e-04 | 7 | 119 | 2 | 12074588 | ||
| Pubmed | 2.41e-04 | 7 | 119 | 2 | 37174615 | ||
| Pubmed | 2.41e-04 | 7 | 119 | 2 | 24236485 | ||
| Pubmed | SR protein kinases promote splicing of nonconsensus introns. | 2.54e-04 | 361 | 119 | 7 | 26167880 | |
| Pubmed | SIPA1L3 FNBP4 VARS2 WRAP53 NSUN2 SHC3 TAF3 AP2A2 FARP1 SMARCC2 PARD3 MTDH LRRFIP1 LRRFIP2 | 2.55e-04 | 1371 | 119 | 14 | 36244648 | |
| Pubmed | 2.59e-04 | 481 | 119 | 8 | 28190767 | ||
| Pubmed | Transcriptome analysis of mouse stem cells and early embryos. | 2.62e-04 | 363 | 119 | 7 | 14691545 | |
| Pubmed | 2.79e-04 | 37 | 119 | 3 | 16949367 | ||
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | PPAN NOP53 MYO18A TACC2 NSUN2 HECTD1 MTDH LRRFIP1 LRRFIP2 WDR24 | 2.90e-04 | 759 | 119 | 10 | 35915203 |
| Pubmed | Activation of Rac GTPase by p75 is necessary for c-jun N-terminal kinase-mediated apoptosis. | 3.02e-04 | 38 | 119 | 3 | 11756498 | |
| Pubmed | 3.21e-04 | 8 | 119 | 2 | 17336282 | ||
| Pubmed | 3.21e-04 | 8 | 119 | 2 | 22006950 | ||
| Pubmed | 3.21e-04 | 8 | 119 | 2 | 1383086 | ||
| Pubmed | Comparative genome mapping in the sequence-based era: early experience with human chromosome 7. | 3.21e-04 | 8 | 119 | 2 | 10810084 | |
| Pubmed | 3.21e-04 | 8 | 119 | 2 | 8617250 | ||
| Pubmed | 3.50e-04 | 503 | 119 | 8 | 16964243 | ||
| Pubmed | HSPG2 SIN3B PPAN NOP53 ZMYND8 MYO18A PSMD12 RREB1 BCOR NSUN2 FAT1 TAF3 DST SMARCC2 | 3.87e-04 | 1429 | 119 | 14 | 35140242 | |
| Pubmed | Identification and characterization of novel substrates of Trk receptors in developing neurons. | 4.11e-04 | 9 | 119 | 2 | 9856458 | |
| Pubmed | Accessory protein recruitment motifs in clathrin-mediated endocytosis. | 4.11e-04 | 9 | 119 | 2 | 12057195 | |
| Pubmed | Perlecan is essential for cartilage and cephalic development. | 4.11e-04 | 9 | 119 | 2 | 10545953 | |
| Pubmed | 4.11e-04 | 9 | 119 | 2 | 19554504 | ||
| Pubmed | Changing expression of chloride channels during preimplantation mouse development. | 4.11e-04 | 9 | 119 | 2 | 23115349 | |
| Pubmed | 4.11e-04 | 9 | 119 | 2 | 21074528 | ||
| Pubmed | Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling. | 4.27e-04 | 281 | 119 | 6 | 28706196 | |
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | NOP53 SYNE1 MYO18A YTHDC1 NSUN2 SHC3 SENP1 DST AP2A2 LRRFIP1 LRRFIP2 | 4.27e-04 | 949 | 119 | 11 | 36574265 |
| Pubmed | 4.36e-04 | 43 | 119 | 3 | 12376548 | ||
| Cytoband | 7q22 | 2.96e-06 | 38 | 119 | 4 | 7q22 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr7q22 | 2.77e-04 | 219 | 119 | 5 | chr7q22 | |
| GeneFamily | Cadherin related | 5.42e-05 | 17 | 80 | 3 | 24 | |
| GeneFamily | CD molecules|Mucins | 1.05e-04 | 21 | 80 | 3 | 648 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 2.08e-04 | 66 | 80 | 4 | 722 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 3.03e-04 | 206 | 80 | 6 | 682 | |
| GeneFamily | PDZ domain containing | 5.69e-04 | 152 | 80 | 5 | 1220 | |
| GeneFamily | Chloride voltage-gated channels | 8.50e-04 | 10 | 80 | 2 | 302 | |
| GeneFamily | Pleckstrin homology domain containing|SH2 domain containing|C2 and RasGAP domain containing | 8.50e-04 | 10 | 80 | 2 | 830 | |
| GeneFamily | WD repeat domain containing | 1.07e-03 | 262 | 80 | 6 | 362 | |
| GeneFamily | WD repeat domain containing|DDB1 and CUL4 associated factors | 2.83e-03 | 18 | 80 | 2 | 498 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | DMGDH FRAS1 ARHGEF28 NEBL SIPA1L3 TACC2 FAT1 FARP1 PARD3 EPB41L1 | 1.18e-10 | 193 | 119 | 10 | 3866667dd221612589ae50f5c52f73a183a49ce6 |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.39e-08 | 194 | 119 | 8 | 7002937e8903e037332a215d00fbc7c7843b33f2 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.39e-08 | 194 | 119 | 8 | 5eaaa81f4b2535f983c424aaef00077089526a5c | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_myocytic-mes_immature_ASM1_(8)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 8.95e-07 | 193 | 119 | 7 | e2b455387d1de7812305200a2041a0f4759a6f54 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.27e-07 | 194 | 119 | 7 | 93c68c31e39fa44c1d05d7d4997f4f086da4e738 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 9.59e-07 | 195 | 119 | 7 | 6477e6e7be5bd8eb99119a12ae16334ccddecd43 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.92e-07 | 196 | 119 | 7 | c7136b1c83bcf907eec3b02b151fa061298b6672 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.92e-07 | 196 | 119 | 7 | 6ce74aa3f0ce3ca284b67e5a4660ffd2cc9611e0 | |
| ToppCell | control|World / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.14e-06 | 200 | 119 | 7 | 97f36d2c197e03d93a1fc59949d77ae90f6e6a9a | |
| ToppCell | NS-control|NS / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.14e-06 | 200 | 119 | 7 | ecbe89ff95d046155b984c8c150e0b9e7278f839 | |
| ToppCell | facs-Lung-Endomucin-24m-Lymphocytic-mature_NK_T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.42e-06 | 159 | 119 | 6 | 4000ed0d3b7d488722bcd0042fa2ff4405aaab82 | |
| ToppCell | facs-Lung-Endomucin-24m-Lymphocytic-Natural_Killer_T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.42e-06 | 159 | 119 | 6 | 7619d0d49738dd08daf01b42664691a5323aa793 | |
| ToppCell | 3'-Adult-LargeIntestine-Epithelial-mature_enterocytic-Paneth|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.67e-06 | 166 | 119 | 6 | b64ab3d13b76bba3c305ebbfc96f983cd6ca30c9 | |
| ToppCell | facs-Lung-24m-Hematologic-lymphocytic-mature_NK_T_cell-mature_NK_T_cell_l22|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.67e-06 | 166 | 119 | 6 | bcdaab49bde5beba750b76fdcc3781a3c12c4fff | |
| ToppCell | facs-Lung-24m-Hematologic-lymphocytic-mature_NK_T_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.67e-06 | 166 | 119 | 6 | 5e3b998d740b24f790fad37350d704ca0ea10b77 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive|renal_medulla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 1.02e-05 | 184 | 119 | 6 | d2bf0135eb56bb410997dccea39c5ede88a0617f | |
| ToppCell | droplet-Lung-LUNG-1m-Epithelial-Club_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.08e-05 | 186 | 119 | 6 | e52cf44989c57c433bf82e9fa13b4643e88f3577 | |
| ToppCell | droplet-Lung-LUNG-1m-Epithelial-club_cell_of_bronchiole|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.08e-05 | 186 | 119 | 6 | 4c0b59d845b79323e7a3287e7c4d249f5f322556 | |
| ToppCell | pdx|World / Sample and Cell Type and Tumor Cluster (all cells) | 1.08e-05 | 186 | 119 | 6 | de8e538c8767d41b8a52f5e58ba1affd4e7244c4 | |
| ToppCell | pdx-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 1.08e-05 | 186 | 119 | 6 | 0b88a87158a9ca8de3bf40a4ff1687150707a5f0 | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Colon_Adenocarcinoma-7|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 1.15e-05 | 188 | 119 | 6 | 14bc73cf79c79c9f208369fd8d498e5b26e0114d | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.15e-05 | 188 | 119 | 6 | 63a4b25a0a6e05f80f1a6dd91b817f3cf49e6b68 | |
| ToppCell | BAL-Severe-Myeloid-TRAM|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.26e-05 | 191 | 119 | 6 | 4c4f50a502e3f6768a89df686fa2830b83b8b33f | |
| ToppCell | BAL-Severe-Myeloid-TRAM|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.26e-05 | 191 | 119 | 6 | de7c88bb46f794291025ef121a89fcd94dea4ffe | |
| ToppCell | CTRL-Myeloid-Alveolar_Macrophage|Myeloid / Disease state, Lineage and Cell class | 1.34e-05 | 193 | 119 | 6 | 80871d963c23a6befe58e5e60b7f7d1a1b227ce2 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.34e-05 | 193 | 119 | 6 | 82e8a4c40299ffcdfd5a0da711bb9de6fb8a2eaa | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_myocytic-mes_immature_ASM1_(8)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.38e-05 | 194 | 119 | 6 | fb80a0271ccb1cb3f954ebcf2c5945cb6adb6b8c | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.38e-05 | 194 | 119 | 6 | 4a2c127c90d1fefe604fcb9e796577d21b489dd6 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.42e-05 | 195 | 119 | 6 | c5d2d9f12fd893331c9de261af30607d845d4f6a | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.46e-05 | 196 | 119 | 6 | eea66711a16134f86e6c533a5a837ff2e0d7ca7f | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.50e-05 | 197 | 119 | 6 | 7e93a97b5ac5ae2f77a4b3141082a1463fed00dd | |
| ToppCell | NS-critical-d_07-13|critical / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.55e-05 | 198 | 119 | 6 | a6e11c87b31beffb6af190c64b4ef3ee1d9dab8d | |
| ToppCell | frontal_cortex-Non-neuronal-oligodendrocyte-Oligo-OPC_Pdgfra_Grm5|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.92e-05 | 133 | 119 | 5 | 63d2f096ae47d9b587acc6c5fbd346e5e58842b8 | |
| ToppCell | 390C-Myeloid-Macrophage-SPP1+_Macrophage_4|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 3.02e-05 | 134 | 119 | 5 | 9e12aac8f42790c2f104dfd61c87aa99fc7925f1 | |
| ToppCell | NS-critical-d_07-13-Epithelial-unknown_epithelial|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.86e-05 | 141 | 119 | 5 | 33ad925ff7be3c682741a6328216a89f9d4033e9 | |
| ToppCell | ILEUM-non-inflamed-(3)_MNP-(3)_pDC|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 8.61e-05 | 167 | 119 | 5 | 8ddf9da71a7c4ed53588435db826563a24cee616 | |
| ToppCell | COVID-19-Heart-Neuronal|COVID-19 / Disease (COVID-19 only), tissue and cell type | 8.86e-05 | 168 | 119 | 5 | 88c2c574f428c2502b5fe099bd73b0758f668ef6 | |
| ToppCell | Control|World / group, cell type (main and fine annotations) | 8.86e-05 | 168 | 119 | 5 | a3511faf2cd2c2b9c8363c8b99da3f3609c43ed6 | |
| ToppCell | COVID-19-kidney-PEC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 8.86e-05 | 168 | 119 | 5 | a086c306be430adf0632ba53e98cd8014d2de330 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 9.37e-05 | 170 | 119 | 5 | a2c738e441ced90eeeb1fcc6ca3269b918aaa298 | |
| ToppCell | Control-Epithelial_cells-ECM-high_epithelial|Control / group, cell type (main and fine annotations) | 9.37e-05 | 170 | 119 | 5 | e2023d66e70983c87dacbd6181d3426488d1fc57 | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.37e-05 | 170 | 119 | 5 | 5570c0e825bca77613bf0ebde620cf744fa1cb84 | |
| ToppCell | Hippocampus-Macroglia-POLYDENDROCYTE-P3|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 9.97e-05 | 90 | 119 | 4 | a0baaf2b3cf07d457f0d242fc213689cba6fd449 | |
| ToppCell | Hippocampus-Macroglia-POLYDENDROCYTE-P3-Tnr|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 9.97e-05 | 90 | 119 | 4 | ab4b08c6ac8695b38f841c0ecf2bb2c032111d04 | |
| ToppCell | Adult-Epithelial-lung_goblet_cell-D231|Adult / Lineage, Cell type, age group and donor | 1.04e-04 | 174 | 119 | 5 | 7d2f802f493f19a068e097b2909a9000e2160266 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.07e-04 | 175 | 119 | 5 | 1d8aab491dcc27ea5dbfb6462d18ee280b21a05e | |
| ToppCell | 390C-Lymphocytic-NK_cells-NK_cell_A2|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.07e-04 | 175 | 119 | 5 | 334fad1a147de6c007cec5089c02c35cf3220f1b | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_B-B_cell-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.07e-04 | 175 | 119 | 5 | 69ed3c7c45df6bef70f5f2ff003531160bf3b32b | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.07e-04 | 175 | 119 | 5 | 427a7ee92fe16a90625946492062d37aa0f7235b | |
| ToppCell | 390C-Lymphocytic-NK_cells-NK_cell_A2|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.07e-04 | 175 | 119 | 5 | da191dfb8a7f976a632a3a0b923942ab54f5c8c1 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma|TCGA-Brain / Sample_Type by Project: Shred V9 | 1.13e-04 | 177 | 119 | 5 | e8ab340b20cd41554c3841fe980e078e878af35f | |
| ToppCell | COVID-19-kidney-Epi_(Mes)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.16e-04 | 178 | 119 | 5 | 544379f5a6145429762258d426b876bb36c112f5 | |
| ToppCell | C_00|World / shred on cell type and cluster | 1.19e-04 | 179 | 119 | 5 | da2dadc3266ffebd4a34ac61bfa05fddcadcde4c | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.19e-04 | 179 | 119 | 5 | cb38b54261a7af5ee3347e64c8aa880a77ed0763 | |
| ToppCell | COVID-19-kidney-Epi_(Mes)|kidney / Disease (COVID-19 only), tissue and cell type | 1.19e-04 | 179 | 119 | 5 | e7c9dc63f03d3f3746b51a7e3c8393089e2ceb7d | |
| ToppCell | droplet-Liver-hepatocytes-3m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.26e-04 | 181 | 119 | 5 | 4df7972f88117108698efd06b124b232f8588981 | |
| ToppCell | droplet-Liver-hepatocytes-3m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.26e-04 | 181 | 119 | 5 | cbb530566893281289026bfd93adf721decd4ca3 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.32e-04 | 183 | 119 | 5 | 6847c1252d6bb105524f812658112517fd351eab | |
| ToppCell | Control-Epithelial_cells-Airway_mucous|Control / group, cell type (main and fine annotations) | 1.32e-04 | 183 | 119 | 5 | 15d24a4fb1ffe6cbafbd54fcd7dde9ddcfbe03b2 | |
| ToppCell | COPD-Epithelial-ATII|World / Disease state, Lineage and Cell class | 1.32e-04 | 183 | 119 | 5 | 8e9aab4eeec2e282c2cab9bfca6dbf40d660c7b9 | |
| ToppCell | facs-Heart-RA-18m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.32e-04 | 183 | 119 | 5 | 0f02136359787bd78146617990968baa47a65d86 | |
| ToppCell | 5'-Adult-LymphNode-Endothelial-blood_vessel_EC-Mature_venous_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.32e-04 | 183 | 119 | 5 | a644258ba90acc62d571623e429d72ffc4b69203 | |
| ToppCell | facs-Heart-RA-18m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.32e-04 | 183 | 119 | 5 | 2f0dcc65ad4d90ef946919b4462280fdd20c5ea0 | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|LV / Chamber and Cluster_Paper | 1.36e-04 | 184 | 119 | 5 | ab7a1620c14a9d9b6be1b47c559931e345e9eef8 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.39e-04 | 185 | 119 | 5 | 98b8ee42b89d97e4c9db01740e0c193503c68f2c | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1-D175|Adult / Lineage, Cell type, age group and donor | 1.39e-04 | 185 | 119 | 5 | 32b4e68e551d435a732f253f6ad83408c759a642 | |
| ToppCell | COPD-Epithelial-Goblet|World / Disease state, Lineage and Cell class | 1.43e-04 | 186 | 119 | 5 | d75fe7640a4b2c450c9759a1b3c3ef2a087f0092 | |
| ToppCell | mild-unassigned|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.43e-04 | 186 | 119 | 5 | 5b2e1a58916f392fa1156bf9210df528775248ff | |
| ToppCell | Control-Epithelial-ATII|World / Disease state, Lineage and Cell class | 1.43e-04 | 186 | 119 | 5 | f4b6e401e19a71beddc73d8a1e08359f7c4025cf | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.46e-04 | 187 | 119 | 5 | 58d48128547ee3513d0bf7f78e61b76b1c472ca9 | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T2|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 1.46e-04 | 187 | 119 | 5 | f3e37c18ac6471c7992609bbddfa4975571c815c | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|LA / Chamber and Cluster_Paper | 1.50e-04 | 188 | 119 | 5 | 34e1b074a3995aa46ab194eb45115d76d1a5514d | |
| ToppCell | COPD-Epithelial-ATII|COPD / Disease state, Lineage and Cell class | 1.50e-04 | 188 | 119 | 5 | eb6d79d733b53f64ca615bb777c64ed456866549 | |
| ToppCell | COPD-Multiplet-Multiplet|World / Disease state, Lineage and Cell class | 1.50e-04 | 188 | 119 | 5 | 186fe1ea328c942910190a4240262c0d8642ea3b | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_osteo-stroma-osteochondral_precursor|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.54e-04 | 189 | 119 | 5 | 1ff4f8da572bdc6356e9df9f41a7f62c81d4c570 | |
| ToppCell | Control-Myeloid-Macrophage_Alveolar|Control / Disease state, Lineage and Cell class | 1.54e-04 | 189 | 119 | 5 | 937e876122bc4b94372a4104e9c1a9068c232018 | |
| ToppCell | renal_medulla_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 1.54e-04 | 189 | 119 | 5 | 830d9cd0dd706bce22eb2416f07b2c31c870a05a | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.58e-04 | 190 | 119 | 5 | 2306aa9dbeaef3be8484a5b236605de23cd75d4c | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Epithelial-podocyte|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.58e-04 | 190 | 119 | 5 | 050d6e0546954675b6adbfecb67854b1e09739d1 | |
| ToppCell | IPF-Myeloid-Macrophage_Alveolar|Myeloid / Disease state, Lineage and Cell class | 1.58e-04 | 190 | 119 | 5 | 2592765016f291565697265800a232b2edef3792 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.58e-04 | 190 | 119 | 5 | 1f83f7f24288a3b9ab33c2e113e845dba96adc8a | |
| ToppCell | 5'-Adult-LymphNode-Endothelial-blood_vessel_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.58e-04 | 190 | 119 | 5 | 141266bf411ea675fbf889b20c1b08673c45ff95 | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|RV / Chamber and Cluster_Paper | 1.58e-04 | 190 | 119 | 5 | fe8e78922c8ae928ef9a80bffd67868d5a87a091 | |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|LV / Chamber and Cluster_Paper | 1.62e-04 | 191 | 119 | 5 | 25f3eb34f4e70761e81e84c8a5829f216108cbc6 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.62e-04 | 191 | 119 | 5 | a0332a4ef629510fb313ec119195c44a3f704a80 | |
| ToppCell | BAL-Severe-Myeloid-TRAM-TRAM3|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.62e-04 | 191 | 119 | 5 | 2b10a73c5d80e83d67a7121fb004a1aa86a537ef | |
| ToppCell | BAL-Severe-Myeloid-TRAM-TRAM3-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.62e-04 | 191 | 119 | 5 | 02e1ae144da7274171e055356d10e8d175c5347f | |
| ToppCell | IPF-Epithelial-Club|World / Disease state, Lineage and Cell class | 1.62e-04 | 191 | 119 | 5 | 3c88a6f1d74bb3b9173cd0ea3a63c6d9570e3954 | |
| ToppCell | Severe_COVID-19-Myeloid-TRAM3|Severe_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 1.62e-04 | 191 | 119 | 5 | 05867b96199a46a415848409130697c810d18937 | |
| ToppCell | Basal_cells-IPF_02|World / lung cells shred on cell class, cell subclass, sample id | 1.62e-04 | 191 | 119 | 5 | a98915bad9a4a61dd4cbca798914849b805f4a19 | |
| ToppCell | Children_(3_yrs)-Epithelial|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.62e-04 | 191 | 119 | 5 | e432c6e1ae82dddf84314ce73d2b7a991630d905 | |
| ToppCell | Control-Multiplet-Multiplet|World / Disease state, Lineage and Cell class | 1.65e-04 | 192 | 119 | 5 | 1bfd022d5b87cf8a5d5069f559339a553a52a0a2 | |
| ToppCell | Epithelial|World / Lineage, Cell type, age group and donor | 1.65e-04 | 192 | 119 | 5 | 499e8893afea5e6d3371e0bd018f7e86a524d669 | |
| ToppCell | BAL-Severe-Myeloid-TRAM-TRAM3|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.65e-04 | 192 | 119 | 5 | 34505a13b8a47c9286c560122fa7861b9c331a08 | |
| ToppCell | COVID-19-Myeloid-TRAM1|COVID-19 / Condition, Lineage and Cell class | 1.65e-04 | 192 | 119 | 5 | 52b8578699325b0d35a2d3ba36772096130ccc0c | |
| ToppCell | BAL-Severe-Myeloid-TRAM-TRAM3-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.65e-04 | 192 | 119 | 5 | 57c1410ebf90c230993e065eb78385daa3360960 | |
| ToppCell | COPD-Epithelial-Goblet|COPD / Disease state, Lineage and Cell class | 1.65e-04 | 192 | 119 | 5 | 93b2ca0a97776d28c7e8f1a0642c4b63a5554aab | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-C|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.65e-04 | 192 | 119 | 5 | 3ce5dbde41aeb73d49f2c7991d34682f0827fa5a | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT2-AT2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.70e-04 | 193 | 119 | 5 | fd4d3c0d7caf8a2fff5b3d901fc28d19a8163cdf | |
| ToppCell | IPF-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 1.70e-04 | 193 | 119 | 5 | ad58f5080e0ba65c845056ea6b79037b636e9c64 | |
| Drug | Acebutolol hydrochloride [34381-68-5]; Up 200; 10.8uM; PC3; HG-U133A | 5.57e-06 | 195 | 112 | 8 | 1911_UP | |
| Drug | Bicuculline (+) [485-49-4]; Down 200; 10.8uM; MCF7; HT_HG-U133A | 6.01e-06 | 197 | 112 | 8 | 2796_DN | |
| Drug | alpha-Santonin [481-06-1]; Down 200; 16.2uM; MCF7; HT_HG-U133A | 6.01e-06 | 197 | 112 | 8 | 3877_DN | |
| Drug | Isoflupredone acetate [338-98-7]; Down 200; 9.6uM; MCF7; HT_HG-U133A | 6.23e-06 | 198 | 112 | 8 | 5545_DN | |
| Drug | MUAC | 1.20e-05 | 29 | 112 | 4 | CID000000366 | |
| Drug | IAA-inositol | 2.40e-05 | 2 | 112 | 2 | CID000152656 | |
| Drug | pioglitazone HCl; Down 200; 10uM; PC3; HT_HG-U133A | 3.44e-05 | 183 | 112 | 7 | 7088_DN | |
| Drug | Fluticasone propionate [80474-14-2]; Up 200; 8uM; MCF7; HT_HG-U133A | 4.67e-05 | 192 | 112 | 7 | 4129_UP | |
| Drug | Nystatine [1400-61-9]; Up 200; 4.4uM; HL60; HT_HG-U133A | 5.15e-05 | 195 | 112 | 7 | 2500_UP | |
| Drug | Beta-sistosterol [83-46-5]; Down 200; 9.6uM; PC3; HT_HG-U133A | 5.15e-05 | 195 | 112 | 7 | 4073_DN | |
| Drug | PHA-00816795 [212631-79-3]; Up 200; 10uM; PC3; HT_HG-U133A | 5.15e-05 | 195 | 112 | 7 | 7072_UP | |
| Drug | Methotrimeprazine maleat salt [7104-38-3]; Down 200; 9uM; MCF7; HT_HG-U133A | 5.32e-05 | 196 | 112 | 7 | 4723_DN | |
| Drug | (-)-Adenosine 3',5'-cyclic monophosphate [60-92-4]; Up 200; 12.2uM; MCF7; HT_HG-U133A | 5.32e-05 | 196 | 112 | 7 | 5533_UP | |
| Drug | Brinzolamide [138890-62-7]; Up 200; 10.4uM; MCF7; HT_HG-U133A | 5.49e-05 | 197 | 112 | 7 | 5016_UP | |
| Drug | Carbinoxamine maleate salt [3505-38-2]; Down 200; 9.8uM; PC3; HT_HG-U133A | 5.49e-05 | 197 | 112 | 7 | 7138_DN | |
| Drug | Meclocycline sulfosalicylate [73816-42-9]; Down 200; 5.8uM; MCF7; HT_HG-U133A | 5.49e-05 | 197 | 112 | 7 | 3277_DN | |
| Drug | 2-propylpentanoic acid; Down 200; 50uM; MCF7; HT_HG-U133A | 5.67e-05 | 198 | 112 | 7 | 5219_DN | |
| Drug | Evoxine [522-11-2]; Down 200; 11.6uM; MCF7; HT_HG-U133A | 5.67e-05 | 198 | 112 | 7 | 4704_DN | |
| Drug | Bupivacaine hydrochloride [18010-40-7]; Down 200; 12.4uM; MCF7; HT_HG-U133A | 5.67e-05 | 198 | 112 | 7 | 5537_DN | |
| Drug | (1-[(4-Chlorophenyl)phenyl-methyl]-4-methylpiperazine) [1620-21-9]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 5.67e-05 | 198 | 112 | 7 | 6053_DN | |
| Drug | U-62066 [87151-85-7]; Down 200; 1uM; MCF7; HT_HG-U133A | 5.67e-05 | 198 | 112 | 7 | 3901_DN | |
| Drug | Aztreonam [78110-38-0]; Down 200; 9.2uM; MCF7; HT_HG-U133A | 5.85e-05 | 199 | 112 | 7 | 5535_DN | |
| Drug | Dimethisoquin hydrochloride [2773-92-4]; Down 200; 13uM; MCF7; HT_HG-U133A | 5.85e-05 | 199 | 112 | 7 | 2807_DN | |
| Drug | 2-Chloropyrazine [14508-49-7]; Down 200; 35uM; PC3; HT_HG-U133A | 6.04e-05 | 200 | 112 | 7 | 5750_DN | |
| Disease | mean corpuscular hemoglobin concentration | HBS1L CUX2 HK1 SLC31A2 BACH2 HECTD4 PSD3 RREB1 RNF43 EHBP1L1 CLCN6 DMRTA1 MTDH CCDC40 | 7.03e-05 | 1105 | 111 | 14 | EFO_0004528 |
| Disease | Macrostomia | 8.37e-05 | 4 | 111 | 2 | C0024433 | |
| Disease | tapasin measurement | 8.37e-05 | 4 | 111 | 2 | EFO_0802118 | |
| Disease | glucose measurement | 9.79e-05 | 380 | 111 | 8 | EFO_0004468 | |
| Disease | FEV/FEC ratio | STARD13 HSPG2 SPRY2 DCHS2 FRAS1 ARHGEF28 NEBL BACH2 ARHGEF18 RREB1 DST ACAN PARD3 CDHR4 | 2.12e-04 | 1228 | 111 | 14 | EFO_0004713 |
| Disease | chronic obstructive pulmonary disease | DCHS2 FRAS1 ZBTB38 ARHGEF28 NEBL BACH2 TSPY26P VARS2 RREB1 DCAF4 | 2.77e-04 | 688 | 111 | 10 | EFO_0000341 |
| Disease | Alzheimer disease, age at onset | 3.26e-04 | 343 | 111 | 7 | EFO_0004847, MONDO_0004975 | |
| Disease | hemoglobin measurement, mean corpuscular hemoglobin concentration | 3.87e-04 | 8 | 111 | 2 | EFO_0004509, EFO_0004528 | |
| Disease | lymphocyte count | HBS1L FRAS1 ZBTB38 PCDHGA10 BACH2 HECTD4 PSD3 ARHGEF18 VARS2 RREB1 ARHGEF11 ZNF469 IKBKE DMRTA1 ARHGEF3 | 3.89e-04 | 1464 | 111 | 15 | EFO_0004587 |
| Disease | basophil count | 4.93e-04 | 483 | 111 | 8 | EFO_0005090 | |
| Disease | non-melanoma skin carcinoma | 5.11e-04 | 265 | 111 | 6 | EFO_0009260 | |
| Disease | spleen volume | 5.73e-04 | 43 | 111 | 3 | EFO_0600047 | |
| Disease | reticulocyte count | HBS1L HK1 ARHGEF28 SLC31A2 HECTD4 RREB1 ZNF469 FAT1 SENP1 DMRTA1 ARHGEF3 DCAF4 | 5.76e-04 | 1045 | 111 | 12 | EFO_0007986 |
| Disease | Kunitz-type protease inhibitor 2 measurement | 6.19e-04 | 10 | 111 | 2 | EFO_0008200 | |
| Disease | cleft lip | 7.34e-04 | 284 | 111 | 6 | EFO_0003959 | |
| Disease | Tremor | 7.54e-04 | 11 | 111 | 2 | C0040822 | |
| Disease | developmental disorder of mental health (implicated_via_orthology) | 8.42e-04 | 49 | 111 | 3 | DOID:0060037 (implicated_via_orthology) | |
| Disease | reaction time measurement | 8.67e-04 | 658 | 111 | 9 | EFO_0008393 | |
| Disease | gout | 8.91e-04 | 196 | 111 | 5 | EFO_0004274 | |
| Disease | stomach carcinoma (is_implicated_in) | 9.03e-04 | 12 | 111 | 2 | DOID:5517 (is_implicated_in) | |
| Disease | alcohol consumption measurement, alcohol drinking | 9.03e-04 | 12 | 111 | 2 | EFO_0004329, EFO_0007878 | |
| Disease | platelet crit | STARD13 HBS1L HK1 BACH2 RREB1 ARHGEF11 SENP1 DMRTA1 ARHGEF3 WDR24 CCDC40 | 9.36e-04 | 952 | 111 | 11 | EFO_0007985 |
| Disease | metabolic syndrome | 9.75e-04 | 200 | 111 | 5 | EFO_0000195 | |
| Disease | HbA1c measurement | 1.04e-03 | 675 | 111 | 9 | EFO_0004541 | |
| Disease | MAP kinase-activated protein kinase 3 measurement | 1.06e-03 | 13 | 111 | 2 | EFO_0008226 | |
| Disease | colorectal cancer (is_implicated_in) | 1.15e-03 | 121 | 111 | 4 | DOID:9256 (is_implicated_in) | |
| Disease | infant head circumference | 1.43e-03 | 15 | 111 | 2 | EFO_0004577 | |
| Disease | severe acute respiratory syndrome, COVID-19 | 1.54e-03 | 447 | 111 | 7 | EFO_0000694, MONDO_0100096 | |
| Disease | Intellectual Disability | 1.54e-03 | 447 | 111 | 7 | C3714756 | |
| Disease | hearing threshold measurement, hearing measurement | 1.59e-03 | 61 | 111 | 3 | EFO_0007616, EFO_0007618 | |
| Disease | Global developmental delay | 1.63e-03 | 133 | 111 | 4 | C0557874 | |
| Disease | Alzheimer disease, polygenic risk score | 1.70e-03 | 586 | 111 | 8 | EFO_0030082, MONDO_0004975 | |
| Disease | C-reactive protein measurement | DMGDH DCHS2 CUX2 ARHGEF28 TMEM79 PSD3 CRTAC1 RREB1 DNAJC6 ZNF469 SMARCC2 DCAF4 | 1.96e-03 | 1206 | 111 | 12 | EFO_0004458 |
| Disease | reticulocyte measurement | HBS1L HK1 ARHGEF28 SLC31A2 HECTD4 RREB1 ZNF469 FAT1 SENP1 DMRTA1 ARHGEF3 | 2.08e-03 | 1053 | 111 | 11 | EFO_0010700 |
| Disease | diabetes mellitus | 2.17e-03 | 68 | 111 | 3 | EFO_0000400 | |
| Disease | hair colour measurement | 2.30e-03 | 615 | 111 | 8 | EFO_0007822 | |
| Disease | serum gamma-glutamyl transferase measurement | DMGDH CUX2 SIPA1L3 HECTD4 PSD3 RREB1 ARHGEF11 PLCG1 PARD3 DCAF4 | 2.39e-03 | 914 | 111 | 10 | EFO_0004532 |
| Disease | atopic eczema | 2.68e-03 | 252 | 111 | 5 | EFO_0000274 | |
| Disease | testosterone measurement | STARD13 DCHS2 CUX2 ACHE FNBP4 PSD3 CRTAC1 VARS2 RREB1 WRAP53 GADL1 PLCG1 | 3.09e-03 | 1275 | 111 | 12 | EFO_0004908 |
| Disease | infant body height | 3.37e-03 | 23 | 111 | 2 | EFO_0006785 | |
| Disease | Moderate albuminuria | 3.45e-03 | 80 | 111 | 3 | HP_0012594 | |
| Disease | cancer (implicated_via_orthology) | 3.49e-03 | 268 | 111 | 5 | DOID:162 (implicated_via_orthology) | |
| Disease | S-7-hydroxywarfarin to S-warfarin ratio measurement | 3.57e-03 | 81 | 111 | 3 | EFO_0803334 | |
| Disease | Sjogren's syndrome (is_marker_for) | 3.67e-03 | 24 | 111 | 2 | DOID:12894 (is_marker_for) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| FGGDPTSVTLFGESA | 221 | P22303 | |
| ADIPSVAFSSRLGGS | 461 | Q8WV16 | |
| TSGRRLEGTDPGTFS | 791 | Q9BYV9 | |
| GEEPGRDSLFSSLAG | 56 | Q6ZSZ5 | |
| LDSEGSFLNPTTGSR | 461 | Q9NR81 | |
| SGLDSGTERFPSLSE | 221 | O15085 | |
| ATEGRGFPASGLATE | 466 | Q9C0C7 | |
| GLISTGSDSESPATR | 1136 | O14529 | |
| TSTLGGLGFSSERNP | 106 | Q6W2J9 | |
| TSGGPTTFAVDRLSG | 481 | A6H8M9 | |
| PSSGGSGLLVDVFSD | 676 | O94973 | |
| RELSGGAEAGTVPTS | 746 | O43374 | |
| GAPDVATLTGGRFSS | 4336 | P98160 | |
| RELSGGAEAGTVPTS | 746 | C9J798 | |
| ESDVGFIPTSGLSGE | 436 | Q9Y450 | |
| LESPSFTGTGDTEIA | 471 | Q08J23 | |
| SSRTGIPSGDELDSF | 506 | Q8N1W1 | |
| SRTSGVLSTTGTPFD | 2026 | Q14517 | |
| SPSGEETAGSVLTLS | 796 | Q8WXI7 | |
| ASSLTPGLRESSGSE | 7826 | Q8WXI7 | |
| SRTESGPGDATLSTI | 10306 | Q8WXI7 | |
| DGSASVGREFIATTP | 731 | Q9H4G0 | |
| SDADSGFLGLRPTSV | 16 | Q9NZM5 | |
| TGTGDRFGPETASDL | 1886 | Q86XX4 | |
| FGPGELDSVGSSSDA | 166 | Q14582 | |
| VGGGSESRSLDSPTS | 426 | Q9P107 | |
| PFDLLIFGSGSDETT | 506 | Q9NS40 | |
| SISGGGTEISQFTPE | 3041 | Q03001 | |
| STPRSLAGLTSGVFE | 231 | Q5HYC2 | |
| SLGTERFSSVAGTPE | 471 | Q14164 | |
| GSTDGLPDLGTESLF | 6 | P0C7V8 | |
| SGVPDRFSGSIDSSS | 76 | P01721 | |
| TGGDAPAFSTSTLLS | 856 | O43157 | |
| SGGSVSIDLGDTSFR | 296 | Q7Z5P9 | |
| RSETTGPLFGLTGTF | 2426 | Q7Z5P9 | |
| SETTRPLDIGSGTTG | 2536 | Q7Z5P9 | |
| GTTRPLAGESGTTES | 2686 | Q7Z5P9 | |
| RTTGSEAPEGTSGEF | 6291 | Q7Z5P9 | |
| EAPEGTSGEFSGTTI | 6296 | Q7Z5P9 | |
| RTTRSEAPGGTSGEF | 6651 | Q7Z5P9 | |
| EAPGEATTLTGDRSS | 6746 | Q7Z5P9 | |
| APAAETTTSLEGGGT | 7426 | Q7Z5P9 | |
| LTASDGGDPLRSGTV | 216 | Q9Y5H3 | |
| STSFRQGPEESGLGD | 726 | Q92614 | |
| GLITGFRSDSSSSLP | 11 | Q9Y6X5 | |
| SRDSGVPGLEADTTG | 781 | Q8N3D4 | |
| SRSSGVPGLESEVAG | 826 | Q8N3D4 | |
| PDFTSLDVLTFAGSG | 371 | Q9NY33 | |
| GSLESPATDVFGSTE | 331 | O00232 | |
| TSVTFLADPSAGGGL | 1961 | Q9Y4D8 | |
| PDSDVRFLLSESGSG | 436 | P19367 | |
| SFSDDGALGPVLTTF | 276 | P52790 | |
| RGSGDTSSLIDPDTS | 326 | Q9Y608 | |
| GLPSGEVLETSASGV | 956 | P16112 | |
| GFPDTSGETSGVTEL | 1741 | P16112 | |
| TSQPFGITDLSGETS | 1776 | P16112 | |
| GLPSGIAEVSGESSR | 1896 | P16112 | |
| GESSRAEIGSSLPSG | 1906 | P16112 | |
| SATPTASGDRTEISG | 2186 | P16112 | |
| VGLDTSVASPSSGGE | 221 | A8K0S8 | |
| EPDTSYGGTLRRSSS | 11 | Q7Z309 | |
| VRDGGFPSLSSTTTI | 1801 | Q6V1P9 | |
| GTLSDTATGAGSEVP | 191 | Q86UR5 | |
| GSVEEGPLSTGSSFI | 731 | O43719 | |
| GPLSTGSSFILSSDD | 736 | O43719 | |
| APIGGTLFSLEEGSS | 256 | P51797 | |
| PEGGSDSSESRSEFL | 711 | Q9ULT8 | |
| GSSVPDVSEGTRSAL | 1261 | Q5THR3 | |
| QSTSLTFGEGAESPG | 391 | Q9Y4F1 | |
| PGTRSAVGELGTESS | 6 | Q9P2H0 | |
| DGDSAGSDSFPVGRT | 71 | O15432 | |
| TSGPAVGRLTGSTEE | 176 | Q4G0X9 | |
| SGGEESPRSLSSSDL | 286 | Q5VZB9 | |
| VPSSGRDGGTSRDTF | 76 | Q19T08 | |
| AFDPSGTDLAVTSLG | 261 | O95390 | |
| LDPFADLGTLGSSSF | 676 | O75061 | |
| FGIDTILSSASSGSP | 11 | Q9NY43 | |
| QSPGEFLLITGSGSE | 586 | Q9UI17 | |
| SDRSIFSGIGSTAEP | 341 | Q86UE4 | |
| RTALPTSGSSAGELE | 411 | Q9Y6I3 | |
| GSGTDFTLTISSLEP | 86 | P04433 | |
| GSTGGLPDLVTESLF | 6 | A6NGE4 | |
| RGVSVGPILSSSASD | 241 | Q9NQ79 | |
| ATSGTTVLGAFDPLD | 271 | Q6ZQY3 | |
| ESGSTLDLSGSRETP | 1116 | Q9ULU4 | |
| LGTPSVLDSDSGVEF | 316 | Q6ZNG9 | |
| SSEDTAPFLGTLAGA | 351 | Q32MZ4 | |
| SETLPAGFRLTTTSG | 1216 | O75334 | |
| TGTQSPEIFGSELGT | 96 | Q8TEW0 | |
| SGSESEGDIFTSPKR | 411 | Q5VWG9 | |
| DSLTARTPSEGEAGT | 1011 | Q5ST30 | |
| GDSAFTSLSVGLPET | 1096 | Q5T011 | |
| GPDLSDSLSSGGVVT | 356 | Q8N1F8 | |
| TDDLPAAFVDGTTSG | 236 | Q6NW40 | |
| FEGNSVSEGRTTPSD | 536 | Q9Y3M8 | |
| LDPTGQFLVSGSTSG | 421 | Q9BUR4 | |
| DELDTSGSVSPTSGR | 8676 | Q8NF91 | |
| LEEGDGSVSGSSPRS | 421 | Q8N3X1 | |
| DDLLPSGVSDRFSGS | 71 | A0A0B4J1U3 | |
| LGSELFSPGGSTRDL | 631 | Q9Y6C5 | |
| ITEGDSFSQSLGPSR | 316 | Q68DV7 | |
| RSISFASGGDPDTTD | 251 | Q92529 | |
| PSSDSFLGSGDLRTF | 76 | Q9P0U3 | |
| VFLFTASSGGLPTDE | 101 | P08842 | |
| SLGGLDPAFTSTEDL | 391 | O60292 | |
| GTEGASSSPTEGFLL | 996 | O75182 | |
| ASPGSEARTTGDISV | 536 | Q16512 | |
| TGAGISTASGIPDFR | 51 | Q8N6T7 | |
| PAFGLESSGIAGTTS | 731 | Q8TAQ2 | |
| LGSSFSSGPVADGII | 136 | O43597 | |
| ESPTGSAESAGIALR | 711 | P51788 | |
| SLSPFEAASLGGSLT | 411 | Q92766 | |
| VGGSDEEASGIPSRT | 356 | Q9NQ55 | |
| SGPSLEDSVGLFLSA | 406 | O15533 | |
| VSGSFTTALDGPSGL | 1791 | P24821 | |
| SLRVGSSAGSPTAIE | 46 | Q9BSE2 | |
| GEAAESSPSFLLGSE | 96 | A0A1W2PR48 | |
| TGAPDGSFLVRESET | 576 | P19174 | |
| SSSLEIPDDFGGRSE | 581 | Q96N46 | |
| ETFLQTLESPGGSGS | 376 | O14492 | |
| SGDLPEAGTTRTFSV | 1721 | O95359 | |
| GSDPVTIFLRDSSGD | 61 | Q9Y279 | |
| GISPIVFDRSGSSAS | 306 | Q96MU7 | |
| GLGRTTAPSSTASDF | 2376 | Q96JG9 | |
| DEVFDSSGLSPGFLG | 136 | O14668 | |
| GSSVLLETGPGDSTL | 256 | Q9UDV6 | |
| GSTSVDSEGFSIPDT | 111 | Q68D20 | |
| ENRIGEFSSTGSTLP | 431 | Q8NAP3 | |
| GPELSSFEGIGTSDL | 736 | P52746 | |
| GLASSALSVFETEPG | 391 | Q96S15 | |
| GRGEAASTATTPSLE | 56 | Q9H489 | |
| ALGEPGLSFTTTDLS | 31 | Q9UL49 | |
| SFDGVSLDSSGPEDR | 1106 | Q6BDS2 | |
| SGTFSPVRLDESGED | 376 | Q9NYI0 | |
| VFERLGPSTGSTAET | 26 | Q5T200 | |
| LPSRSEEGSFSQGTV | 1046 | Q96L42 | |
| DTALSPGSTTALSFG | 1061 | Q9UKN1 | |
| DTALSPGSTTALSFG | 3701 | Q9UKN1 | |
| SSTFGTGLGDDRSEI | 886 | O76041 |